Altrius Capital Management Inc Boosts Stock Holdings in The Cigna Group (NYSE:CI)

Altrius Capital Management Inc lifted its position in shares of The Cigna Group (NYSE:CI) by 6.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,416 shares of the health services provider’s stock after buying an additional 856 shares during the period. Altrius Capital Management Inc’s holdings in The Cigna Group were worth $3,981,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Collier Financial purchased a new position in shares of The Cigna Group in the 4th quarter worth about $32,000. ORG Wealth Partners LLC purchased a new position in The Cigna Group in the fourth quarter valued at approximately $34,000. Prospera Private Wealth LLC acquired a new position in The Cigna Group during the third quarter valued at approximately $37,000. Compagnie Lombard Odier SCmA purchased a new stake in The Cigna Group during the fourth quarter worth approximately $37,000. Finally, Harbor Capital Advisors Inc. acquired a new stake in shares of The Cigna Group in the third quarter worth $45,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

The Cigna Group Stock Performance

Shares of CI opened at $303.39 on Friday. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The firm has a market cap of $84.39 billion, a price-to-earnings ratio of 24.79, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company’s fifty day moving average is $288.90 and its 200-day moving average is $318.87.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the business earned $6.79 earnings per share. Equities analysts expect that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be given a dividend of $1.51 per share. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a yield of 1.99%. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s payout ratio is 49.35%.

Analyst Ratings Changes

CI has been the subject of several recent research reports. Morgan Stanley lowered their price target on The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Truist Financial lowered their price objective on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating for the company in a research report on Tuesday, February 4th. Barclays decreased their target price on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Raymond James restated a “strong-buy” rating and set a $360.00 target price (down from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $372.31.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.